金運激光(300220.SZ):4名股東合計減持629.99萬股
格隆匯1月3日丨金運激光(300220.SZ)公佈,樑偉、樑芳、易淑梅、嶽萍芳於減持期間合計減持629.99萬股,減持比例5.000%。
此次權益變動之前,信息披露義務人樑偉持有金運激光約6353.5萬股,佔金運激光總股本的50.42%。
此次權益變動後易淑梅(與樑偉為母子關係)、嶽萍芳(與樑偉為夫妻關係)持有金運激光0股,樑芳(與樑偉為姐弟關係)個人賬户持有金運激光0股。此次權益變動後,信息披露義務人樑偉持有金運激光約5763.27萬股,佔金運激光總股本的45.74%。
信息披露義務人根據其減持計劃不排除在未來 12 個月內繼續減持金運激光 股份的可能,並按法律法規的規定履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.